Normothermic machine perfusion for the assessment and transplantation of declined human kidneys from donation after circulatory death donors by Hosgood SA et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License 
 
 
Newcastle University ePrints - eprint.ncl.ac.uk 
 
Hosgood SA, Thompson E, Moore T, Wilson CH, Nicholson ML. 
Normothermic machine perfusion for the assessment and transplantation of 
declined human kidneys from donation after circulatory death donors. 
British Journal of Surgery 2018, 105(4), 388–394. 
 
 
Copyright: 
© 2017 The Authors. BJS published by John Wiley & Sons Ltd on behalf of BJS Society Ltd. This is an open 
access article under the terms of the Creative Commons Attribution-NonCommercial License, which 
permits use, distribution and reproduction in any medium, provided the original work is properly cited 
and is not used for commercial purposes. 
DOI link to article: 
https://doi.org/10.1002/bjs.10733  
Date deposited:   
06/03/2018 
 
Original article
Normothermic machine perfusion for the assessment and
transplantation of declined human kidneys from donation after
circulatory death donors
S. A. Hosgood1, E. Thompson2, T. Moore1, C. H. Wilson2 and M. L. Nicholson1
1Department of Surgery, University of Cambridge, Cambridge, and 2Freeman Hospital, Newcastle University, Newcastle upon Tyne, UK
Correspondence to: Dr S. A. Hosgood, Department of Surgery, Level 9, PO Box 202, University of Cambridge, Addenbrooke’s Hospital, Cambridge
CB2 0QQ, UK (e-mail: sh744@cam.ac.uk)
Background: A significant proportion of donation after circulatory death (DCD) kidneys are declined
for transplantation because of concerns over their quality. Ex vivo normothermic machine perfusion
(NMP) provides a unique opportunity to assess the quality of a kidney and determine its suitability for
transplantation.
Methods: In phase 1 of this study, declined humanDCD kidneys underwent NMP assessment for 60min.
Kidneys were graded 1–5 using a quality assessment score (QAS) based on macroscopic perfusion, renal
blood flow and urine output during NMP. In phase 2 of the study, declined DCD kidneys were assessed
by NMP with an intention to transplant them.
Results: In phase 1, 18 of 42 DCD kidneys were declined owing to poor in situ perfusion. After NMP, 28
kidneys had a QAS of 1–3, and were considered suitable for transplantation. In phase 2, ten of 55 declined
DCD kidneys underwent assessment by NMP. Eight kidneys had been declined because of poor in situ
flushing in the donor and five of these were transplanted successfully. Four of the five kidneys had initial
graft function.
Conclusion: NMP technology can be used to increase the number of DCD kidney transplants by
assessing their quality before transplantation.
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Introduction
Over the past decade the proportion of donation after
circulatory death (DCD) kidneys used in transplantation
has increased significantly1. Although this is a welcome
trend, DCD kidneys are associated with an increased risk
of delayed graft function and sometimes suboptimal renal
function2,3. Up to 15 per cent of these kidneys that are
retrieved are subsequently declined for transplantation4.
Kidneys are declined for many reasons but the decision
always has an element of subjectivity. It is possible that
a significant number of transplantable kidneys are incor-
rectly deemed unsuitable.
Normothermic machine perfusion (NMP) is a novel
organ preservation system designed using cardio-
pulmonary bypass technology. A warmed, oxygenated,
non-inflammatory red cell-based solution is pumped
through the kidney in an organ chamber5,6. This
allows ex vivo restoration of function, and provides
a unique opportunity to assess the quality of a kid-
ney objectively and to inform the decision whether to
transplant.
The aim of this study was to develop NMP as a technol-
ogy to assess and then transplant DCD kidneys that had
been deemed unsuitable for transplantation. The study
had two phases. In phase 1, declined DCD kidneys were
assessed by NMP to determine what proportion might be
suitable for transplantation. This was an assessment phase
only, with no intention to proceed to transplantation.
In phase 2, DCD kidneys that were deemed unsuitable
for transplantation were assessed by NMP with the aim
of transplanting kidneys that met defined assessment
parameters.
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Methods
In phase 1, from December 2012 to June 2014, DCD
kidneys from the national organ allocation scheme
that were declined for transplantation were recruited
into this research project. Ethical approval was granted
by the national ethical approval committee in the UK
(12/EM/0143).
In phase 2, fromNovember 2015 to February 2017, after
agreement fromNational Health Service Blood and Trans-
plant (NHSBT), kidneys offered through the National
Kidney Allocation Fast-track Scheme that were subse-
quently declined for transplantation by all UK transplant
centres were recruited into the study.
In both phases, consent for recruitment of the kidney
into the study was obtained from the donor family by
specialist nurses in organ donation. Ethical approval to
transplant kidneys that had been deemed unsuitable was
granted by the national ethical approval committee in the
UK (15/EE/0175).
The following inclusion criteria were applied: kidneys
declined for transplantation because of adverse donor char-
acteristics; poor in situ perfusion in the donor; prolonged
ischaemia; adverse gross appearance; histological evidence
of chronic damage; and adverse cold perfusion parame-
ters. In addition, donors and recipients had to be at least
18 years old, and recipients were undergoing a first or
second renal transplant from a deceased donor. Kidneys
were not recruited if deemed unsuitable for transplantation
based on contraindications defined by current NHSBT
criteria7, if they had irreparable vascular damage, or if the
recipient was having a third or subsequent transplant.
A suitable recipient was identified and, on arrival of the
kidney at the transplant centre, it underwent a period of
NMP under aseptic conditions in the operating theatre.
If the kidney was deemed suitable for transplantation, the
recipient was prepared for the transplant procedure in the
usual way.
Normothermic machine perfusion
Kidneys were prepared for transplantation and perfusion.
The renal artery was cannulated, or where possible a
patch cannula was attached to the Carrel aortic patch
for connection to the circuit. The renal vein and ureter
were also cannulated. Kidneys were perfused with an oxy-
genated red blood cell-based solution mixed with a prim-
ing solution for 60min at 35⋅0–36⋅0 ∘C. Supplements were
infused to replace urine output and maintain a physiologi-
cal environment5,6. After perfusion, kidneys were flushed
with 1 litre of hyperosmolar citrate solution (Soltran®;
Baxter Healthcare, Thetford, UK) and placed on ice until
transplanted.
Quality assessment parameters
During NMP, renal blood flow was monitored continu-
ously and recorded every 5min, and the total urine output
measured. Blood gas analysis of arterial and venous blood
was used to record acid–base homeostasis and measure
oxygen consumption.
Blood samples were taken before perfusion and after
60min ofNMP. A urine sample was also taken after 60min.
The NMP quality assessment score (QAS) was derived
as a composite of three factors8: macroscopic appearance,
mean renal blood flow and total urine output. Kidneys with
a QAS score of 3 or less were considered suitable for trans-
plantation provided there were no other preclusions to
transplant8. The oxygen consumption was calculated at the
end of NMP using arterial and venous blood gas samples,
as (arterial PO2 – venous PO2)× renal blood flow/weight,
where PO2 is the partial pressure of oxygen.
A sample of urine was taken from the kidney after
60min of NMP to measure levels of neutrophil
gelatinase-associated lipocalin (NGAL) using a human
NGAL sandwich enzyme-linked immunosorbent assay kit
(Cohesion Biosciences, London, UK). The samples were
centrifuged at 516 g at 4 ∘C for 10min, then stored at
–70 ∘C until analysis.
Histopathological assessment
The Remuzzi score9 was calculated by a consultant pathol-
ogist for all kidneys in phase 1 and where necessary in phase
2. Haematoxylin and eosin-stained 4-μm sections cut from
wedge biopsies taken at the end of cold storage were used.
Kidney sections were also assessed for the degree of acute
tubular injury, which was graded as mild, mild to moderate,
moderate or severe.
Transplantation
Kidneys were transplanted into the right iliac fossa, with
anastomosis of the artery and vein to the external iliac
vessels, and the ureter to the bladder as an extravesical onlay
over a double J stent.
Immunosuppression
All patients were immunosuppressed with a standard reg-
imen of basiliximab (20mg on days 0 and 4), tacrolimus
(0⋅1mg per kg per day to maintain trough levels of
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Table 1 Donor and surgical demographics for phase 1
Reason for decline
Inadequate in situ
perfusion (n=18)
Malignancy
(n=2)
Technical factor/
injury (n=5)
Long CIT
(n=8)
HMP parameters
(n=4)
Past medical
history (n= 5)
Age (years)* 54(16) 67(4) 63(7) 73(6) 66(5) 46(19)
Sex ratio (M : F) 14 : 4 0 : 2 2 : 3 5 : 3 3 : 1 5 : 0
BMI (kg/m2)* 25⋅7(4⋅6) 34⋅7(13⋅1) 30⋅6(14⋅5) 26⋅0(3⋅7) 30⋅4(10⋅2) 24⋅2(0⋅6)
KDRI† 1⋅32 1⋅97 1⋅40 2⋅57 1⋅73 1⋅05
(0⋅80–2⋅17) (1⋅96–1⋅97) (1⋅27–1⋅51) (1⋅72–2⋅67) (1⋅56–1⋅86) (0⋅82–2⋅03)
Cause of death
Intracranial haemorrhage 11 0 4 2 0 1
Pulmonary disease 4 0 1 2 2 0
Congestive cardiac failure 2 0 0 0 0 0
Hypoxic brain injury 0 1 0 2 2 1
Cardiac arrest 1 1 0 0 0 3
Myocardial infarct 0 0 0 2 0 0
Creatinine before retrieval (μmol/l)* 89(36) 203(152) 81(61) 118(21) 133(111) 293(166)
WIT (min)* 12(2) 14(1) 12(7) 14(4) 16(2) 12(2)
CIT (h)* 24⋅2(15⋅9) 23⋅4(15⋅7) 31⋅2(5⋅4) 23⋅2(10⋅5) 28⋅4(10⋅7) 25⋅5(3⋅2)
Values are *mean(s.d.) and †median (range). CIT, cold ischaemia time; HMP, hypothermic machine perfusion; KDRI, Kidney Donor Risk Index;
WIT, warm ischaemia time.
6–10 ng/ml), mycophenolate mofetil (500mg twice daily)
and prednisolone (20mg daily).
Statistical analysis
Donor information recorded included: age, sex, ethnicity,
cause of death, Kidney Donor Risk Index (KDRI)10, past
medical history, BMI and serum creatinine level. Surgical
parameters were also recorded, including: warm ischaemia
time, cold ischaemia time, preservation solution used, and
the quality of cold perfusion flush on the back bench as
scored subjectively by retrieving surgeons.
Continuous data are presented as mean(s.d.) and median
(range), as appropriate. Data were analysed using t test or
Mann–Whitney U test. P< 0⋅050 was considered statisti-
cally significant.
Results
Phase 1
A total of 42 DCD kidneys were included in the phase 1
cohort. The majority were declined because of poor in situ
perfusion (18) (Table 1). Other reasons were: malignancy
(2), technical factors (5), long cold ischaemia time (8), poor
hypothermic machine perfusion parameters (4) or specific
donor characteristics (5). Donor age ranged from 26 to
79 years. Most donors were white; two kidneys were from
black donors and two from Asian donors. The majority
were men (29 of 42). The mean(s.d.) warm ischaemia time
was 14(4) min and the mean cold ischaemia time before
Table 2 Reason for decline and normothermic perfusion quality
assessment score in phase 1
Quality assessment score
1–3 4–5
Inadequate perfusion 14 4
Malignancy 2 0
Technical/anatomical 5 0
Long CIT 3 5
HMP parameters 2 2
Past medical history 2 3
Total 28 14
CIT, cold ischaemia time; HMP, hypothermic machine perfusion.
commencing NMP was 27⋅0(9⋅6) h. The mean terminal
creatinine level was 114(73) μmol/l. ThemedianKDRI was
1⋅80 (range 0⋅80–2⋅67).
The majority of QAS scores in phase 1 kidneys were
between 1 and 3 (28 of 42), and these kidneys were there-
fore considered suitable for transplantation. Table 2 shows
the association between the reason for decline and the
NMP QAS. Most kidneys declined owing to inadequate
in situ perfusion had a favourable QAS. Those kidneys
declined because of a long cold ischaemia time (at the
time of offer) did not perform well during NMP, with
five of eight receiving a score of 4 or 5, meaning they
were unsuitable for transplantation. The kidneys declined
owing to poor hypothermic machine perfusion parame-
ters also did not perform well during 1 h of NMP per-
fusion, with two of the four receiving an unfavourable
QAS.
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Declined human DCD kidneys offered n = 55
Kidneys recruited n = 10Kidneys not recruited n = 45
Reasons for national decline n = 10
 Poor in situ perfusion n = 8
 Donor age n = 2
Primary reason kidneys not recruited n = 45
 Prolonged CIT n = 12
 Donor history n = 6
 Damage to vessels n = 3
 Recipient not suitable n = 3
 Histology n = 5
 Abnormal anatomy n = 10
 Prolonged WIT n = 2
 Malignancy n = 2
 Not available n = 2
Reasons for national decline n = 45
 Poor in situ perfusion n = 7
 Donor history n = 6
 Damage to vessels n = 4
 Recipient not suitable n = 3
 Histology n = 2
 Abnormal anatomy n = 12
 Prolonged WIT n = 4
 Prolonged CIT n = 2
 Malignancy n = 2
 Unknown n = 3
Kidneys not transplanted n = 5
 Delayed access to operating theatre n = 1
 Abnormal appearance n = 1
 High Remuzzi score n = 2
 QAS 4 n = 1
Fig. 1 Phase 2 study: flow diagram listing the number of offers, kidneys not recruited, reasons for national decline, reasons for
non-recruitment, number of kidneys recruited and assessed, and reasons for decline and for not transplanting. DCD, donation after
circulatory death; WIT, warm ischaemia time; CIT, cold ischaemia time; QAS, quality assessment score
Phase 2
Fifty-five kidneys from 37 DCD donors were offered
for research (Fig. 1). Ten kidneys from six donors were
recruited into the study; the remaining 45 were not
recruited. The reasons why all UK units initially declined
the 45 DCD kidneys are listed in Fig. 1. At the time of
being offered for this research project, further information
was sometimes unavailable and the cold storage interval
had been lengthened because of the logistics of the offering
scheme. Prolonged cold ischaemia time became the final
reason for not recruiting 12 kidneys (22 per cent) into the
study.
Eight of the ten recruited kidneys were declined pri-
marily owing to inadequate in situ perfusion; one of these
also had a stripped ureter. One kidney was from a donor
who had undergone 109min of normothermic regional
perfusion before organ retrieval11,12. The remaining two
kidneys, which were from the same donor, were declined
because of age (78 years). The donor demographics are
detailed in Table S1 (supporting information). The appear-
ance of the kidneys with inadequate in situ perfusion ranged
from a global mottled appearance to areas of segmental
non-perfusion covering 20–50 per cent of the organ.
Perfusion parameters
All kidneys were perfused for 60min at mean(s.d.) arterial
BP of 77(5) mmHg/ml and temperature of 35⋅3(0⋅2) ∘C.
Five of the ten kidneys were not transplanted. The first
(K03) had a QAS score of 3 but, owing to delayed access
to the operating theatre, which would prolong the cold
ischaemia time further, the decision was made by the
implanting surgeon not to transplant the kidney. The sec-
ond (K04) also had a QAS score of 3. Before NMP, the kid-
ney was mottled globally. Despite renal blood flow above
the threshold, the global appearance was unchanged after
perfusion when the kidney was flushed with cold preserva-
tion solution, and the decision not to transplant was made
by the transplanting surgeon. The pair of kidneys from
the 78-year-old donor had a QAS score of 1 (left kidney)
and 4 (right). However, the Remuzzi scores were 6 and
7 respectively, and the kidneys were deemed not suitable
for transplantation13. The last kidney (K10) had a QAS
score of 4 and was therefore considered unsuitable for
transplantation.
Five kidneys were transplanted successfully (Table 3). The
first pair (K01 and K02) had QAS values of 1 and 2
respectively. K05 had a QAS of 3; this kidney also had
© 2017 The Authors. BJS published by John Wiley & Sons Ltd www.bjs.co.uk BJS 2018; 105: 388–394
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Table 3 Clinical data for transplanted kidneys and demographics
of the recipients
K01 K02 K05 K08 K09
Transplanted kidneys
First CIT (h) 17⋅4 19⋅7 18⋅9 7⋅8 9⋅5
NMP (min) 60 60 60 60 60
Second CIT (min) 132 247 187 503 187
Anastomosis (min) 33 33 39 34 38
Total duration of ischaemia (h) 21⋅2 26⋅4 23⋅7 17⋅8 14⋅2
Recipients
Age 30 68 55 49 45
Sex M F M M M
HLA mismatch 0-1-1 2-1-0 2-2-0 2-1-0 2-1-0
Previous transplant No No No Yes 1 No
Dialysis HD CAPD HD HD CAPD
Delayed graft function No No Yes No No
Creatinine (μmol/l)
Before transplant 834 558 733 741 588
7days 115 550 681 600 311
1month 101 143 514 155 175
3months 106 143 408 116 167
6months 124 192 292
Acute rejection No No No No No
Duration of hospital stay (days) 5 9 9 7 6
CIT, cold ischaemia time; NMP, normothermic machine perfusion; HD,
haemodialysis; CAPD, continuous ambulatory peritoneal dialysis.
a stripped ureter. The kidney was a little patchy at the
start of perfusion but improved thereafter. The ureter was
vascularized adequately. The kidney also had an upper
polar artery that had been cut, and this was ligated leading
to a 3× 3-cm area of infarction. The last pair (K08 andK09)
had QAS values of 2.
After NMP, the kidneys were flushed with cold preserva-
tion solution then stored on ice until transplantation. This
second cold ischaemia time ranged from 132 to 503min.
The total amount of urine produced during NMP was
significantly less in the kidneys that were not transplanted
(mean 344(172) versus 41(29) ml for transplanted and
not transplanted kidneys respectively; P= 0⋅008) (Fig. 2).
There were no other significant differences in the perfusion
parameters between the transplanted and non-transplanted
kidneys. Urinary levels of NGAL were numerically lower
in the transplanted kidneys (P= 0⋅055) (Fig. S1, supporting
information).
Outcomes
One patient (K05) had delayed graft function requiring
dialysis for 3weeks after transplant (Table 3). The 3-month
biopsy showed ongoing acute tubular necrosis with some
tacrolimus toxicity. Kidney function improved with the
serum creatinine level falling from 408 μmol/l at 3months
to 292 μmol/l at 6months. K08 required one episode
of dialysis after transplant owing to hyperkalaemia. The
mean(s.d.) hospital stay was 7⋅2(1⋅8) days.
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Fig. 2 aMean(s.d.) renal blood flow during normothermic
perfusion of the transplanted and non-transplanted kidneys and
b total urine output. Values for individual patients are also shown
Discussion
This study demonstrated that NMP technology can be
used to assess and transplant DCD kidneys that have pre-
viously been deemed unsuitable for transplantation. Five
kidneys were transplanted successfully after being rejected,
primarily owing to inadequate in situ perfusion in the
donor. This is the only current experience of the trans-
plantation of human kidneys that had been deemed unsuit-
able for transplantation. Four of five transplants functioned
immediately without recourse to dialysis. The only kidney
with delayed graft function had suboptimal renal function,
with a recipient serum creatinine of 292 μmol/l at 6months.
This kidney had a QAS of 3, which was the highest value
in the transplanted group. The level of NGAL measured
in the urine after NMP was also high in this kidney, sug-
gesting poorer quality. NGAL is a marker of tubular injury,
and has been found previously to have a strong association
withNMP functional parameters and donor history14. Fur-
ther experience, and possibly refinement of the QAS, may
© 2017 The Authors. BJS published by John Wiley & Sons Ltd www.bjs.co.uk BJS 2018; 105: 388–394
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be required to achieve an acceptably low incidence of sub-
optimal results.
There was a low yield of transplanted kidneys from the
potential pool of declined DCD organs. Over a 14-month
interval, 55 declined DCD kidneys were offered to the
study, but only ten of these proceeded to NMP assessment
with intent to transplant them. Eight kidneys undergoing
NMP assessment were declined because of inadequate in
situ perfusion in the donor and two were from an older
donor. The reasons for not proceeding to NMP assess-
ment in 45 of the 55 kidneys offered were often multi-
factorial, and included suspected malignancy, adverse renal
anatomy, vascular damage, past medical history such as
severe hypertension and diabetes, infection and prolonged
cold ischaemia. The low yield of transplanted kidneys has
been a reflection of a relatively cautious approach at the
start of this initiative.
Inadequate in situ perfusion is common in DCD kidney
transplantation14,15. The accumulation of thrombi in the
microcirculation, anatomy of the kidney, improper place-
ment of the perfusion cannula, vasospasm, atherosclerosis
and renal artery stenosis can be contributing factors. It has
been demonstrated previously14, and confirmed here, that
a large proportion of kidneys declined because of inade-
quate in situ perfusion can regain function during NMP
and, based on the perfusion parameters, may be suitable
for transplantation. In the phase 1 study, 18 of the 42 kid-
neys (43 per cent) were declined owing to inadequate in
situ perfusion, and three-quarters of these kidneys had a
QAS score of 1 to 3, suggesting potential suitability for
transplantation.
Prolonged cold storage was the commonest reason
for not proceeding to assessment by NMP in phase 2.
Cold storage time is an independent risk factor for
reduced graft survival and is associated with delayed graft
function16,17. DCD kidneys have, by definition, had a
period of warm ischaemia and are especially sensitive to
added cold ischaemic injury17. This informed the cautious
approach here to kidneys with prolonged cold ischaemia.
The kidneys recruited into this study were offered as
research kidneys after being declined through the national
organ-sharing and the fast-tracking schemes. The current
logistics of the allocation system meant that prolonged
cold ischaemia times were often unavoidable. The cold
ischaemia time before NMP was in excess of 16 h in three
of the five transplanted kidneys in this series. The total
ischaemia time was over 24 h in one kidney and approached
24 h in another two. The authors were particularly reluc-
tant to recruit kidneys that were offered with a combination
of older donor age and prolonged cold ischaemia, as this
combination of factors is known to be associated with poor
outcomes16. Furthermore, the Cambridge unit has a policy
that mandates histological assessment of all kidneys from
donors aged 60 years or more. Pretransplant biopsies are
assessed using the Remuzzi scoring system9,18. Although
this can provide valuable information on chronic damage
it also prolongs the cold ischaemia time by 4–6 h.
After NMP the kidney must be flushed with cold preser-
vation solution to clear the microcirculation of the red
cell-based perfusion solution. The kidney is then stored in
ice until transplantation. This inevitable second interval of
cold ischaemia lasted more than 2 h in all five transplanted
kidneys; the longest duration was 8⋅4 h. The principle of
intermediate NMP followed by a relatively long second
cold storage period has already been described19. This sug-
gests that it would be possible to have regional perfusion
hubs that assessed marginal kidneys by NMP and then
repackaged suitable organs in ice for transport to another
centre for transplantation. This concept has already been
established for ex vivo lung perfusion20.
NMP allows the successful transplantation of DCD kid-
neys that had been deemed unsuitable for transplanta-
tion, and has potential to increase the number of kidney
transplants. There is, however, a pressing need to access
declined DCD kidneys more quickly in order to increase
the rate of assessment by NMP and the transplant rate.
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